Novo Pharmaceuticals PVT LTD is an Indian Non-Government Company ... work to increase availability and curb the use of less-regulated alternatives. Novartis CEO 'very confident' on sales target, doesn ...

Zeal Pharmaceuticals PVT LTD registered address is 160/B RASH BEHARI AVENUE KOLKATA WB 700029 IN. Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas ...

Paul Hudson, CEO of the pharmaceutical firm Sanofi, has an argument for letting AI make top-level decisions in medicine: It has no attachments. Speaking at a panel in Davos on Tuesday, Hudson said ...

Takeda Pharmaceutical 4502-0.74%decrease ... president of its U.S. business unit, will succeed CEO Christophe Weber, who plans to step down in June next year.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...

UnitedHealth Group 2024 revenue reached over $400 billion with adjusted EPS of $27.66. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...

He was named president and representative director in June 2014, and subsequently appointed CEO in April 2015 ... and any written or oral material discussed or distributed by Takeda Pharmaceutical ...

Feb. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals ... today announced its participation in the 2025 BIO CEO & Investor Conference being held February 10-11, 2025, at the New York Marriott ...

The Market Online speaks with Voyageur Pharmaceuticals CEO, Brent Willis as Voyageur Begins Testing of Innovative Barium Contrast Product Line in Human Radiology Scans. Major coffee chain ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

Ian Mortimer, President and CEO of Xenon Pharmaceuticals Inc. (NASDAQ:XENE), recently reported a series of transactions involving the company's common shares. According to a filing with the ...

WEST CONSHOHOCKEN, PA—William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale ...